News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Biotechnology Industry Organization (BIO) Commends Supreme Court for Expansive View of Patentability in Bilski Decision
June 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) released the following statement in reaction to the Supreme Court’s decision to uphold the lower court’s ruling in Bilski v. Kappos.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Biotechnology Innovation Organization (BIO)
MORE ON THIS TOPIC
Obesity
Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement
January 6, 2026
·
2 min read
·
Tristan Manalac
Legal
Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme
December 23, 2025
·
2 min read
·
Nick Paul Taylor
Drug pricing
Trump Administration Reaches Pricing Agreements With 9 More Drugmakers
December 22, 2025
·
2 min read
·
Nick Paul Taylor
Policy
Disc Shares Slip Amid Report FDA’s Prasad Is Skeptical of Bitopertin’s Efficacy
December 22, 2025
·
2 min read
·
Nick Paul Taylor